A statistical investigation of parameters associated with low cell-free fetal DNA fraction in maternal plasma for noninvasive prenatal testing

References

• Mandel P, Metais P. Nuclear acids in human blood plasma. C R Seances Soc Biol Fil. 1948;142(3–4):1–11.
   Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–487. doi: 10.1016/S0140-6736(97)02174-0.
   PubMed Web of Science ®Google Scholar
• Ashoor G, Syngelaki A, Poon LC, et al. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol. 2013;41(1):26–32. doi: 10.1002/uog.12331.
   PubMed Web of Science ®Google Scholar
• Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect down syndrome: an international clinical validation study. Genet Med. 2011;13(11):913–920. doi: 10.1097/GIM.0b013e3182368a0e.
   PubMed Web of Science ®Google Scholar
• Fiorentino F, Bono S, Pizzuti F, et al. The importance of determining the limit of detection of noninvasive prenatal testing methods. Prenat Diagn. 2016;36(4):304–311. doi: 10.1002/pd.4780.
   PubMed Web of Science ®Google Scholar
• Guy GP, Hargrave J, Dunn R, et al. Secondary noninvasive prenatal screening for fetal trisomy: an effectiveness study in a public health setting. BJOG. 2021;128(2):440–446. doi: 10.1111/1471-0528.16464.
   PubMed Web of Science ®Google Scholar
• Cserhati M. Calculation of fetal fraction for noninvasive prenatal testing. BioTech. 2021;10(3):17. doi: 10.3390/biotech10030017.
   Google Scholar
• Deng C, Liu S. Factors affecting the fetal fraction in noninvasive prenatal screening: a review. Front Pediatr. 2022;10:812781. doi: 10.3389/fped.2022.812781.
   PubMed Web of Science ®Google Scholar
• Hou Y, Yang J, Qi Y, et al. Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for noninvasive prenatal screening. Hum Genomics. 2019;13(1):62. doi: 10.1186/s40246-019-0244-0.
   PubMed Web of Science ®Google Scholar
• Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014;211(5):527 e521–527 e517. doi: 10.1016/j.ajog.2014.08.006.
   Web of Science ®Google Scholar
• Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify down syndrome and other trisomies in multiple gestations. Prenat Diagn. 2012;32(8):730–734. doi: 10.1002/pd.3892.
   PubMed Web of Science ®Google Scholar
• Struble CA, Syngelaki A, Oliphant A, et al. Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis. Fetal Diagn Ther. 2014;35(3):199–203. doi: 10.1159/000355653.
   PubMed Web of Science ®Google Scholar
• Hedriana H, Martin K, Saltzman D, et al. Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening. Prenat Diagn. 2020;40(2):179–184. doi: 10.1002/pd.5609.
   PubMed Web of Science ®Google Scholar
• Norwitz ER, McNeill G, Kalyan A, et al. Validation of a Single-Nucleotide Polymorphism-Based Non-Invasive prenatal test in twin gestations: determination of zygosity, individual fetal sex, and fetal aneuploidy. J Clin Med. 2019;8(7):937. doi: 10.3390/jcm8070937.
   PubMed Web of Science ®Google Scholar
• Sarno L, Revello R, Hanson E, et al. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy. Ultrasound Obstet Gynecol. 2016;47(6):705–711. doi: 10.1002/uog.15913.
   PubMed Web of Science ®Google Scholar
• Revello R, Sarno L, Ispas A, et al. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result. Ultrasound Obstet Gynecol. 2016;47(6):698–704. doi: 10.1002/uog.15851.
   PubMed Web of Science ®Google Scholar
• Scott FP, Menezes M, Palma-Dias R, et al. Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy. J Matern Fetal Neonatal Med. 2018;31(14):1865–1872. doi: 10.1080/14767058.2017.1330881.
   PubMed Web of Science ®Google Scholar
• Yuan X, Han X, Jia C, et al. Low fetal fraction of cell free DNA at noninvasive prenatal screening increases the subsequent risk of preterm birth in uncomplicated singleton pregnancy. Int J Womens Health. 2022;14:889–897. doi: 10.2147/IJWH.S364554.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Chai X, Liu N, et al. FF-QuantSC: accurate quantification of fetal fraction by a neural network model. Mol Genet Genomic Med. 2020;8(6):e1232.
   PubMed Web of Science ®Google Scholar
• Yaron Y. The implications of noninvasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn. 2016;36(5):391–396. doi: 10.1002/pd.4804.
   PubMed Web of Science ®Google Scholar
• Benn P, Valenti E, Shah S, et al. Factors associated with informative redraw after an initial no result in noninvasive prenatal testing. Obstet Gynecol. 2018;132(2):428–435. doi: 10.1097/AOG.0000000000002728.
   PubMed Web of Science ®Google Scholar
• Putra M, Plunkett K, Liu Y, et al. NIPT redraw success rates after a single experience with updated SNP algorithm. Am J Obstet Gynecol. 2023;228(1):S181. doi: 10.1016/j.ajog.2022.11.342.
   Web of Science ®Google Scholar
• Haghiac M, Vora NL, Basu S, et al. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity. 2012;20(11):2213–2219. doi: 10.1038/oby.2012.138.
   PubMed Web of Science ®Google Scholar
• Vora NL, Johnson KL, Basu S, et al. A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI. Prenat Diagn. 2012;32(9):912–914. doi: 10.1002/pd.3919.
   PubMed Web of Science ®Google Scholar
• Duc Son LN, Kusama K, Hung NT, et al. Prevalence and risk factors for diabetes in Ho chi Minh City, Vietnam. Diabet Med. 2004;21(4):371–376. doi: 10.1111/j.1464-5491.2004.01159.x.
   PubMed Web of Science ®Google Scholar
• Moses RG, Goluza I, Borchard JP, et al. The prevalence of diabetes after gestational diabetes – an Australian perspective. Aust N Z J Obstet Gynaecol. 2017;57(2):157–161. doi: 10.1111/ajo.12581.
   PubMed Web of Science ®Google Scholar
• Chen M, Jiang F, Guo Y, et al. Validation of fetal DNA fraction estimation and its application in noninvasive prenatal testing for aneuploidy detection in multiple pregnancies. Prenat Diagn. 2019;39(13):1273–1282. doi: 10.1002/pd.5597.
   PubMed Web of Science ®Google Scholar
• Guo FF, Yang JX, Huang YL, et al. Association between fetal fraction at the second trimester and subsequent spontaneous preterm birth. Prenat Diagn. 2019;39(13):1191–1197. doi: 10.1002/pd.5566.
   PubMed Web of Science ®Google Scholar
• Qiao L, Yu B, Liang Y, et al. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing. Am J Obstet Gynecol. 2019;221(4):345 e341–345 e311. doi: 10.1016/j.ajog.2019.05.023.
   Web of Science ®Google Scholar
• Lee TJ, Rolnik DL, Menezes MA, et al. Cell-free fetal DNA testing in singleton IVF conceptions. Hum Reprod. 2018;33(4):572–578. doi: 10.1093/humrep/dey033.
   PubMed Web of Science ®Google Scholar
• McKanna T, Ryan A, Krinshpun S, et al. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA. Ultrasound Obstet Gynecol. 2019;53(1):73–79. doi: 10.1002/uog.19176.
   PubMed Web of Science ®Google Scholar
• Hestand MS, Bessem M, van Rijn P, et al. Fetal fraction evaluation in noninvasive prenatal screening (NIPS). Eur J Hum Genet. 2019;27(2):198–202. doi: 10.1038/s41431-018-0271-7.
   PubMed Web of Science ®Google Scholar
• Bevilacqua E, Gil MM, Nicolaides KH, et al. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies. Ultrasound Obstet Gynecol. 2015;45(1):61–66. doi: 10.1002/uog.14690.
   PubMed Web of Science ®Google Scholar
• Fosler L, Winters P, Jones KW, et al. Aneuploidy screening by noninvasive prenatal testing in twin pregnancy. Ultrasound Obstet Gynecol. 2017;49(4):470–477. doi: 10.1002/uog.15964.
   PubMed Web of Science ®Google Scholar
• Wegrzyn P, Faro C, Falcon O, et al. Placental volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol. 2005;26(1):28–32. doi: 10.1002/uog.1923.
   PubMed Web of Science ®Google Scholar